Nano-X Posts ~$4M in Preliminary Q2 Revenue, Cash Dwindles to $31.4M, and Flags Going Concern
NNOX sits 33% above its 52-week low of $0.734.
Summary
Nano-X Imaging reported preliminary Q2 2026 revenue of $4.0–$4.1 million and cash of $31.4 million, down from $60.0 million six months earlier, and warned that cash is insufficient to fund operations for the next year, raising substantial doubt about its ability to continue as a going concern.
Key Events · Earnings and Guidance · NNOX
-
Going Concern Warning Reiterated
Management states that cash of $31.4 million as of June 30, 2026, is insufficient to fund operations for at least one year, raising substantial doubt about the company's ability to continue as a going concern.
-
Cash Burn Accelerates
Cash, cash equivalents, and deposits fell from $60.0 million at December 31, 2025, to approximately $31.4 million at June 30, 2026 — a burn of roughly $28.6 million in six months.
-
Preliminary Q2 Revenue of $4.0–$4.1M
Revenue increased from $3.0 million in Q2 2025, driven by teleradiology ($2.9M), AI/software ($1.0M), and imaging systems ($0.2M). AI revenue growth reflects consolidation of Vaso Healthcare IT.
-
Commercial Progress Amid Liquidity Crisis
Signed a new U.S. Nanox.ARC CapEx agreement, completed first Nanox Imaging Network installation in Philadelphia, and entered a UK reseller agreement for Nanox.AI Bone with Vertec Scientific.
Analysis · NNOX · Industrial Applications And Services
Preliminary Q2 2026 revenue of $4.0–$4.1 million, up from $3.0 million a year ago, was overshadowed by a sharp cash decline to $31.4 million from $60.0 million at year-end 2025. Management warned that current cash is insufficient to fund operations for at least one year, raising substantial doubt about the company's ability to continue as a going concern. This warning follows a similar alert in Q1 and withdrawn guidance, deepening the liquidity crisis. While the company is actively seeking capital, there is no assurance of success. The filing also highlights commercial progress — a new U.S. Nanox.ARC deal, first imaging network installation, and a UK reseller agreement — but these are overshadowed by the acute cash burn and survival risk.
At the time of this filing, NNOX was trading at $0.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $67.8M. The 52-week trading range was $0.73 to $5.55. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.